{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T13:32:50Z","timestamp":1784986370442,"version":"3.55.0"},"reference-count":54,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2025.2042","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T11:57:58Z","timestamp":1754999878000},"page":"1-11","source":"Crossref","is-referenced-by-count":1,"title":["Expression of Oct3\/4 isoforms and its association with the risk of relapse in acute lymphoblastic leukemia"],"prefix":"10.3892","volume":"23","author":[{"given":"Jorge","family":"Organista\u2011Nava","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Biomedicine, Faculty of Chemical and Biological Sciences, Autonomous University of Guerrero, Chilpancingo, Guerrero 39090, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazm\u00edn","family":"G\u00f3mez\u2011G\u00f3mez","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biomedicine, Faculty of Chemical and Biological Sciences, Autonomous University of Guerrero, Chilpancingo, Guerrero 39090, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corayma","family":"G\u00f3mez\u2011S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biomedicine, Faculty of Chemical and Biological Sciences, Autonomous University of Guerrero, Chilpancingo, Guerrero 39090, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Salmer\u00f3n\u2011B\u00e1rcenas","sequence":"additional","affiliation":[{"name":"Department of Molecular Biomedicine, Center for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV\u2011IPN) 07360, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma Isabel","family":"Zubillaga\u2011Guerrero","sequence":"additional","affiliation":[{"name":"Laboratory of Cytopathology and Immunohistochemistry, Faculty of Chemical Biological Sciences, Autonomous University of Guerrero, Chilpancingo, Guerrero 39090, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Bertha","family":"Rivera\u2011Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Research department, \u2018Arturo Beltr\u00e1n Ortega\u2019 Cancer Institute, Acapulco, Guerrero 39570, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica Virginia","family":"Saavedra\u2011Herrera","sequence":"additional","affiliation":[{"name":"Research department, \u2018Arturo Beltr\u00e1n Ortega\u2019 Cancer Institute, Acapulco, Guerrero 39570, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Alvarez\u2011Palacios","sequence":"additional","affiliation":[{"name":"Research department, \u2018Arturo Beltr\u00e1n Ortega\u2019 Cancer Institute, Acapulco, Guerrero 39570, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Israel","family":"Torres\u2011Rojas","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biomedicine, Faculty of Chemical and Biological Sciences, Autonomous University of Guerrero, Chilpancingo, Guerrero 39090, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz Del Carmen","family":"Alarc\u00f3n\u2011Romero","sequence":"additional","affiliation":[{"name":"Laboratory of Cytopathology and Immunohistochemistry, Faculty of Chemical Biological Sciences, Autonomous University of Guerrero, Chilpancingo, Guerrero 39090, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenice","family":"Illades\u2011Aguiar","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biomedicine, Faculty of Chemical and Biological Sciences, Autonomous University of Guerrero, Chilpancingo, Guerrero 39090, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Antonio","family":"Leyva\u2011V\u00e1zquez","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biomedicine, Faculty of Chemical and Biological Sciences, Autonomous University of Guerrero, Chilpancingo, Guerrero 39090, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"key20250903134335_b1-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"key20250903134335_b2-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1634\/theoncologist.5-4-321","article-title":"The role of prognostic features in the treatment of childhood acute lymphoblastic leukemia","volume":"5","author":"Friedmann","year":"2000","journal-title":"Oncologist"},{"key":"key20250903134335_b3-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N Engl J Med"},{"issue":"165432","key":"key20250903134335_b4-BR-23-4-02042","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.03.005","article-title":"Role of OCT4 in cancer stem-like cells and chemotherapy resistance","volume":"1866","author":"Mohiuddin","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"e577","key":"key20250903134335_b5-BR-23-4-02042","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.53","article-title":"Acute lymphoblastic leukemia: A comprehensive review and 2017 update","volume":"7","author":"Terwilliger","year":"2017","journal-title":"Blood Cancer J"},{"key":"key20250903134335_b6-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s13402-013-0142-8","article-title":"The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients","volume":"36","author":"Di","year":"2013","journal-title":"Cell Oncol (Dordr)"},{"key":"key20250903134335_b7-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bbagrm.2013.10.001","article-title":"OCT4: dynamic DNA binding pioneers stem cell pluripotency","volume":"1839","author":"Jerabek","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"key20250903134335_b8-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/j.bbadis.2014.07.015","article-title":"Overexpression of Oct4 suppresses the metastatic potential of breast cancer cells via Rnd1 downregulation","volume":"1842","author":"Shen","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"e0118033","key":"key20250903134335_b9-BR-23-4-02042","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118033","article-title":"The differential expression of OCT4 isoforms in cervical carcinoma","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"key20250903134335_b10-BR-23-4-02042","first-page":"1029","article-title":"The POU5F1P1 pseudogene encodes a putative protein similar to POU5F1 isoform 1","volume":"20","author":"Panagopoulos","year":"2008","journal-title":"Oncol Rep"},{"key":"key20250903134335_b11-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"608","DOI":"10.22074\/cellj.2016.3832","article-title":"Altered expression of high molecular weight heat shock proteins after OCT4B1 suppression in human tumor cell lines","volume":"17","author":"Mirzaei","year":"2016","journal-title":"Cell J"},{"key":"key20250903134335_b12-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3892\/ol.2011.415","article-title":"CD133, OCT4, and NANOG in ulcerative colitis-associated colorectal cancer","volume":"2","author":"Yasuda","year":"2011","journal-title":"Oncol Lett"},{"key":"key20250903134335_b13-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1002\/pros.22867","article-title":"Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer","volume":"74","author":"Guzel","year":"2014","journal-title":"Prostate"},{"key":"key20250903134335_b14-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/path.4383","article-title":"Wnt\/\u03b2-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4","volume":"234","author":"Lee","year":"2014","journal-title":"J Pathol"},{"issue":"130","key":"key20250903134335_b15-BR-23-4-02042","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0130-5","article-title":"Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer","volume":"31","author":"Kong","year":"2014","journal-title":"Med Oncol"},{"issue":"1010428317716629","key":"key20250903134335_b16-BR-23-4-02042","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317716629","article-title":"Expression of embryonic stem cell markers in acute myeloid leukemia","volume":"39","author":"Picot","year":"2017","journal-title":"Tumour Biol"},{"key":"key20250903134335_b17-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1089\/scd.2017.0134","article-title":"Potential role of OCT4 in leukemogenesis","volume":"26","author":"Picot","year":"2017","journal-title":"Stem Cells Dev"},{"key":"key20250903134335_b18-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"9711","DOI":"10.1007\/s13277-015-3731-5","article-title":"High expression of OCT4 is frequent and may cause undesirable treatment outcomes in patients with acute myeloid leukemia","volume":"36","author":"Yin","year":"2015","journal-title":"Tumour Biol"},{"key":"key20250903134335_b19-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1080\/10245332.2018.1482050","article-title":"Octamer-binding transcription factor 4 correlates with complex karyotype, FLT3-ITD mutation and poorer risk stratification, and predicts unfavourable prognosis in patients with acute myeloid leukaemia","volume":"23","author":"Xiang","year":"2018","journal-title":"Hematology"},{"key":"key20250903134335_b20-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1136\/hrt.2008.145383","article-title":"Non-invasive gene-expression-based detection of well-developed collateral function in individuals with and without coronary artery disease","volume":"95","author":"Meier","year":"2009","journal-title":"Heart"},{"key":"key20250903134335_b21-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1056\/NEJMoa033513","article-title":"Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment","volume":"351","author":"Holleman","year":"2004","journal-title":"N Engl J Med"},{"key":"key20250903134335_b22-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1210\/jc.2007-0979","article-title":"Gene expression in peripheral blood mononuclear cells from children with diabetes","volume":"92","author":"Kaizer","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key20250903134335_b23-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccr.2006.09.006","article-title":"Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance","volume":"10","author":"Wei","year":"2006","journal-title":"Cancer Cell"},{"key":"key20250903134335_b24-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3892\/etm.2012.447","article-title":"Survival and risk of relapse of acute lymphoblastic leukemia in a Mexican population is affected by dihydrofolate reductase gene polymorphisms","volume":"3","author":"G\u00f3mez-G\u00f3mez","year":"2012","journal-title":"Exp Ther Med"},{"key":"key20250903134335_b25-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1182\/blood.2021012328","article-title":", et al: Remission, treatment failure, and relapse in pediatric ALL: An international consensus of the Ponte-di-Legno Consortium","volume":"139","author":"Buchmann","year":"2022","journal-title":"Blood"},{"key":"key20250903134335_b26-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1002\/ijc.25643","article-title":"OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor","volume":"128","author":"Asadi","year":"2011","journal-title":"Int J Cancer"},{"key":"key20250903134335_b27-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/nprot.2006.236","article-title":"Quantification of mRNA using real-time RT-PCR","volume":"1","author":"Nolan","year":"2006","journal-title":"Nat Protoc"},{"key":"key20250903134335_b28-BR-23-4-02042","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1182\/blood.V84.2.421.421","article-title":"Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34","volume":"84","author":"DiGiusto","year":"1994","journal-title":"Blood"},{"issue":"23","key":"key20250903134335_b29-BR-23-4-02042","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-016-0080-5","article-title":"CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia","volume":"4","author":"Jiang","year":"2016","journal-title":"Biomark Res"},{"issue":"100850","key":"key20250903134335_b30-BR-23-4-02042","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2021.100850","article-title":"Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities","volume":"50","author":"O'Reilly","year":"2021","journal-title":"Blood Rev"},{"key":"key20250903134335_b31-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"key20250903134335_b32-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/stem.419","article-title":"Concise review: Isoforms of OCT4 contribute to the confusing diversity in stem cell biology","volume":"28","author":"Wang","year":"2010","journal-title":"Stem Cells"},{"key":"key20250903134335_b33-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"33554","DOI":"10.1074\/jbc.M603937200","article-title":"The human OCT-4 isoforms differ in their ability to confer self-renewal","volume":"281","author":"Lee","year":"2006","journal-title":"J Biol Chem"},{"key":"key20250903134335_b34-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/ijc.22508","article-title":"OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer","volume":"120","author":"Atlasi","year":"2007","journal-title":"Int J Cancer"},{"key":"key20250903134335_b35-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1634\/stemcells.2008-0530","article-title":"OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells","volume":"26","author":"Atlasi","year":"2008","journal-title":"Stem Cells"},{"issue":"247","key":"key20250903134335_b36-BR-23-4-02042","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00247","article-title":"Role of Oct3\/4 in cervical cancer tumorigenesis","volume":"10","author":"Clemente-Periv\u00e1n","year":"2020","journal-title":"Front Oncol"},{"issue":"e760","key":"key20250903134335_b37-BR-23-4-02042","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.272","article-title":"OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b\/BAK1 pathway","volume":"4","author":"Wang","year":"2013","journal-title":"Cell Death Dis"},{"key":"key20250903134335_b38-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s11033-022-07988-9","article-title":"The expression of Oct3\/4A mRNA and not its isoforms is upregulated by the HPV16 E7 oncoprotein","volume":"50","author":"G\u00f3mez-G\u00f3mez","year":"2023","journal-title":"Mol Biol Rep"},{"key":"key20250903134335_b39-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bcmd.2014.07.014","article-title":"Aberrant expression and significance of OCT-4A transcription factor in leukemia cells","volume":"54","author":"Zhao","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"key20250903134335_b40-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41388-018-0487-6","article-title":"OCT4B mediates hypoxia-induced cancer dissemination","volume":"38","author":"Lin","year":"2019","journal-title":"Oncogene"},{"key":"key20250903134335_b41-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.canlet.2011.05.027","article-title":"OCT4B1, a novel spliced variant of OCT4, generates a stable truncated protein with a potential role in stress response","volume":"309","author":"Farashahi Yazd","year":"2011","journal-title":"Cancer Lett"},{"issue":"5","key":"key20250903134335_b42-BR-23-4-02042","doi-asserted-by":"publisher","DOI":"10.1186\/s43046-024-00209-3","article-title":"Significance of OCT3\/4 and SOX2 antigens expression by leukemic blast cells in adult acute leukemia","volume":"36","author":"Aref","year":"2024","journal-title":"J Egypt Natl Canc Inst"},{"key":"key20250903134335_b43-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"30844","DOI":"10.18632\/oncotarget.9602","article-title":"Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer","volume":"8","author":"Lu","year":"2017","journal-title":"Oncotarget"},{"key":"key20250903134335_b44-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"36305","DOI":"10.18632\/oncotarget.16750","article-title":"Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance","volume":"8","author":"Gwak","year":"2017","journal-title":"Oncotarget"},{"key":"key20250903134335_b45-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.yexcr.2018.01.002","article-title":"In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity","volume":"363","author":"Gatti","year":"2018","journal-title":"Exp Cell Res"},{"key":"key20250903134335_b46-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/hep.23692","article-title":"Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway","volume":"52","author":"Wang","year":"2010","journal-title":"Hepatology"},{"key":"key20250903134335_b47-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1038\/onc.2011.656","article-title":"Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation","volume":"31","author":"Kumar","year":"2012","journal-title":"Oncogene"},{"key":"key20250903134335_b48-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1002\/hep.28821","article-title":"Octamer 4\/microRNA-1246 signaling axis drives Wnt\/\u03b2-catenin activation in liver cancer stem cells","volume":"64","author":"Chai","year":"2016","journal-title":"Hepatology"},{"issue":"36612","key":"key20250903134335_b49-BR-23-4-02042","doi-asserted-by":"publisher","DOI":"10.1038\/srep36612","article-title":"An active IGF-1R-AKT signaling imparts functional heterogeneity in ovarian CSC population","volume":"6","author":"Singh","year":"2016","journal-title":"Sci Rep"},{"issue":"10","key":"key20250903134335_b50-BR-23-4-02042","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-31-10","article-title":"Clinicopathological significance of non-small cell lung cancer with high prevalence of Oct-4 tumor cells","volume":"31","author":"Chen","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"issue":"447","key":"key20250903134335_b51-BR-23-4-02042","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15040447","article-title":"Distinct phenotypic and molecular characteristics of CD34- and CD34+ hematopoietic stem\/progenitor cell subsets in cord blood and bone marrow samples: Implications for clinical applications","volume":"15","author":"Gaafar","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"key20250903134335_b52-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1080\/16078454.2022.2080368","article-title":"The prognostic effect on childhood acute lymphoblastic leukemia of CD34(+)CD38(-) expressed in leukemia cells","volume":"27","author":"Zhao","year":"2022","journal-title":"Hematology"},{"key":"key20250903134335_b53-BR-23-4-02042","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3892\/or.2018.6491","article-title":"Oct4 promotes cancer cell proliferation and migration and leads to poor prognosis associated with the survivin\/STAT3 pathway in hepatocellular carcinoma","volume":"40","author":"Wang","year":"2018","journal-title":"Oncol Rep"},{"issue":"10357","key":"key20250903134335_b54-BR-23-4-02042","doi-asserted-by":"publisher","DOI":"10.1038\/srep10357","article-title":"Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer","volume":"5","author":"Cioffi","year":"2015","journal-title":"Sci Rep"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T10:43:44Z","timestamp":1756896224000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2025.2042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":54,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8,12]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2025.2042","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}